Estradiol and Progesterone in Hospitalized COVID-19 Patients
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine to what extent a short systemic steroid therapy
with estradiol and progesterone, administered early to hospitalized and confirmed COVID-19
positive patients of both sexes in addition to standard of care (SOC) can reduce the severity
of symptoms and outcomes compared to SOC alone.